跳至主要内容
临床试验/NCT07716410
NCT07716410招募中不适用

A Prospective Study to Characterize the Clinical Presentation and Course of Cryptosporidium in Pediatric Participants With Symptomatic Cryptosporidiosis in Endemic Countries

Novartis Pharmaceuticals4 个研究点 分布在 3 个国家目标入组 30 人开始时间: 2026年1月9日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
4
主要终点
Number and Percentage of Participants by Chronicity of Diarrhea

研究概览

简要总结

This study aims to characterize the pediatric cryptosporidiosis disease profile with respect to clinical presentation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
6 Months 至 59 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Age 6 months to 59 months with diarrhea according to the World Health Organization (WHO) criteria (≥3 loose stools daily for at least 2 days)
  • QuikChek™ and Stool microscopy positive for Cryptosporidium at screening
  • Acute (<7 days), prolonged (lasting 7-13 days), persistent (lasting 14-28 days) or chronic (lasting >28 days) diarrheal illness (≥3 loose stools daily, as defined by WHO) at screening
  • Normal nutritional status, mildly-to-moderately acutely malnourished, or severely acutely malnourished according to WHO definitions (number of participants with severe acute malnutrition will be capped) at screening
  • Parent or primary caregiver is willing to provide informed consent and to comply with study procedures, including provision of whole stool samples at the scheduled time points and willing to be followed up to 21 days

排除标准

  • Bloody diarrhea, defined as diarrhea with visible blood in stool as observed by the study team member performing the screening or reported by parent/primary caregiver
  • Other morbidity requiring emergency medical care in an intensive care setting at the time of screening
  • Coincident non-enteric infection including upper or lower respiratory infection at screening
  • Any participant whose parent or primary caregiver is unwilling or unable to cooperate with study procedures, in the investigator's opinion
  • If the parent/primary caregiver managing care of the patient has travel plans out of the study area that would preclude clinic or in-home study visits during the expected study follow-up period
  • Other protocol-defined inclusion/exclusion criteria may apply.

结局指标

主要结局

Number and Percentage of Participants by Chronicity of Diarrhea

时间窗: Baseline

Diarrhea chronicity categories: * Acute (\<7 days) * Prolonged (7-13 days) * Persistent (14-28 days) * Chronic (\>28 days)

Number and Percentage of Participants by Severity of Dehydration

时间窗: Baseline, Days 3, 7, 14 and up to Day 21

Dehydration severity categories: * None * Some * Severe

Time to Resolution of Diarrhea and Dehydration

时间窗: Baseline, Days 3, 7, 14 and up to Day 21

次要结局

  • Association of Diarrheal Chronicity With Age(Baseline)
  • Association of Diarrheal Chronicity With Height(Baseline)
  • Association of Diarrheal Chronicity With Weight(Baseline)
  • Association of Diarrheal Chronicity With Sex(Baseline)
  • Association of Diarrheal Chronicity With HIV Status(Baseline)
  • Association of Diarrheal Chronicity With Malnutrition(Baseline)
  • Association of Diarrheal Chronicity With Growth Faltering(Baseline)
  • Association of Diarrheal Chronicity With Early Weaning(Baseline)
  • Association of Diarrheal Chronicity With Non-Exclusive Breast Feeding(Baseline)
  • Association of Dehydration Severity With Age(Baseline, Days 3, 7, 14 and up to Day 21)
  • Association of Dehydration Severity With Height(Baseline, Days 3, 7, 14 and up to Day 21)
  • Association of Dehydration Severity With Weight(Baseline, Days 3, 7, 14 and up to Day 21)
  • Association of Dehydration Severity With Sex(Baseline, Days 3, 7, 14 and up to Day 21)
  • Association of Dehydration Severity With HIV Status(Baseline, Days 3, 7, 14 and up to Day 21)
  • Association of Dehydration Severity With Malnutrition(Baseline, Days 3, 7, 14 and up to Day 21)
  • Association of Dehydration Severity With Growth Faltering(Baseline, Days 3, 7, 14 and up to Day 21)
  • Association of Dehydration Severity With Early Weaning(Baseline, Days 3, 7, 14 and up to Day 21)
  • Association of Dehydration Severity With Non-Exclusive Breast Feeding(Baseline, Days 3, 7, 14 and up to Day 21)
  • Number of Oocysts(Baseline, Days 3, 7, 14 and up to Day 21)
  • Proportion of Participants Shedding Oocysts(Baseline, Days 3, 7, 14 and up to Day 21)
  • Number of Participants by Parasite Presence Measured by Microscopy and the QuikChek™ Cryptosporidium Rapid Diagnostic Test (RDT)(Baseline, Days 3, 7, 14 and up to Day 21)
  • Number of Participants Screened for Each Site by Time of Year(Baseline)
  • Number of Participants Enrolled for Each Site by Time of Year(Baseline)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

A Study to Characterize the Clinical Presentation... | 临床试验